The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial

M. A. Fischl, D. D. Richman, N. Hansen, A. C. Collier, J. T. Carey, M. F. Para, W. D. Hardy, R. Dolin, W. G. PowDerly, J. D. Allan, B. Wong, T. C. Merigan, V. C. McAuliffe, N. E. Hyslop, F. S. Rhame, H. J. Balfour, S. A. Spector, P. Volberding, C. Pettinelli, J. Anderson

Research output: Contribution to journalArticlepeer-review

548 Scopus citations

Fingerprint

Dive into the research topics of 'The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences